NIH-funded research R01 grant

Improving large-scale detection of emerging pathogens using advanced sequencing technology

Official title: Expanding Swabseq sequencing technology to enable readiness for emerging pathogens

Funded at University of California Los Angeles · NIH-10886137 · Data updated 2026-11-12

This study is working on a new way to quickly and accurately find germs like COVID-19 by testing many samples at the same time, making it easier for more labs to help keep everyone safe.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 11, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$575,226
NIH project number5R01AI177859-02
Project IDNIH-10886137 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who may be asymptomatic carriers of emerging pathogens or those in high-risk environments requiring frequent testing.

Less likely to help

Patients who are not at risk for emerging pathogens or those who do not require frequent testing may not benefit from this research.

What this research studies

This research focuses on developing enhanced methods for detecting novel pathogens, such as COVID-19, through a large-scale testing approach. By utilizing next-generation sequencing technology, the study aims to analyze hundreds of thousands of samples simultaneously. Each sample is labeled with a unique DNA barcode, allowing for efficient pooling and testing of multiple samples at once. This method not only increases testing capacity but also aims to make high-throughput testing accessible to more laboratories.

Why it matters

Potential benefit: If successful, this research could significantly improve the speed and efficiency of pathogen detection, leading to better public health responses during outbreaks.

How similar studies have gone: Previous research has shown success with similar high-throughput sequencing approaches in pathogen detection, particularly during the COVID-19 pandemic.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Eskin, Eleazar — University of California Los Angeles
  • Study coordinator: Eskin, Eleazar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.